Filtern
Volltext vorhanden
- ja (72)
Gehört zur Bibliographie
- ja (72)
Erscheinungsjahr
Dokumenttyp
- Artikel / Aufsatz in einer Zeitschrift (72) (entfernen)
Sprache
- Englisch (72) (entfernen)
Schlagworte
- breast cancer (18)
- ovarian cancer (7)
- 3D printing (4)
- expression (4)
- gynecology (4)
- survival (4)
- education (3)
- inflammation (3)
- ketogenic diet (3)
- teaching (3)
- Akt (2)
- BRENDA (2)
- CD39 (2)
- CD73 (2)
- Ketogenic diet (2)
- Metastatic breast cancer (2)
- NSG (2)
- T cells (2)
- VEGF (2)
- adenosine (2)
- apoptosis (2)
- autophagy (2)
- blood-brain barrier (2)
- cancer (2)
- cancer detection and diagnosis (2)
- cytokines (2)
- disease (2)
- gene (2)
- humanized mice (2)
- immune escape (2)
- lymph nodes (2)
- pelvic examination (2)
- pelvic palpation (2)
- pregnancy (2)
- stress (2)
- trastuzumab (2)
- tumor stem cells (2)
- visualization (2)
- 2-APB (1)
- 3D tissue model (1)
- 3D-conformal radiotherapy (1)
- ADCC (1)
- Astrocytic tumor (1)
- Axonal degeneration (1)
- B7-H1 (1)
- Blood–brain barrier (1)
- Blut (1)
- CD74 (1)
- COVID-19 (1)
- CX3CL1 (1)
- CXCL13 (1)
- Ca2+ release activated Ca2+ channel (1)
- Chirurgie (1)
- Coronavirus Disease 2019 (1)
- Covid-19 (1)
- DNA repair protraction (1)
- Diabetic polyneuropathy (1)
- Epidural Analgesia (1)
- Expression (1)
- FDM (1)
- FWGE (1)
- Fettgehalt (1)
- Genetic causes of cancer (1)
- Glioblastoma cell line (1)
- Glioblastoma multiforme (1)
- HER2 (1)
- HER2 conversion (1)
- HER2 targeted therapy (1)
- HER2-low (1)
- HERV-K (1)
- HLA class II (1)
- HLA peptidome (1)
- Health care service research (1)
- Healthcare Cost (1)
- Healthcare Economics (1)
- High fat diet (1)
- Human endogenous retrovirus (1)
- In vitro models (1)
- Ketogene Kost (1)
- Krebs <Medizin> (1)
- Krebskranker (1)
- L. reuteri (1)
- LPS (1)
- Labour Analgesia (1)
- Labour Pain (1)
- Large loop excision of the transformation zone (LLETZ) (1)
- Lebensqualität (1)
- Loop electrosurgical excision procedure (LEEP) (1)
- MMP (1)
- MRSA (1)
- MRSA - methicillin-resistant Staphylococcus aureus (1)
- Matrix metalloproteinases (1)
- Medicine (1)
- Medizin (1)
- Molecular biology (1)
- Motor nerve biopsy (1)
- NRG1 (1)
- NSG-SGM3 (1)
- NVP-BEZ235 (1)
- Nectin‐2 (1)
- Neuropathy (1)
- Neurotrophic factors (1)
- Non-coding RNAs (1)
- Novel PI3K (1)
- PC-1 blockade (1)
- PCR analysis (1)
- PD-1 (1)
- PD-L1 (1)
- Parkinson’s disease (1)
- Patient Controlled Analgesia (1)
- Patient Satisfaction (1)
- Patient-centered registry (1)
- Patient’s needs (1)
- Pelvisio® (1)
- RT-qPCT (1)
- Remifentanil (1)
- SH-6 (1)
- SLA (1)
- SOCE (1)
- Severe Acute Respiratory Syndrome Coronavirus 2 (1)
- Staphylococcus aureus (1)
- Staphylococcus aureus immune response (1)
- T-DM1 (1)
- TGF-beta (1)
- TKTL1 (1)
- Toll-like receptor signaling (1)
- UME6 (1)
- VE-cadherin (1)
- accessibility (1)
- acute respiratory distress syndrome (1)
- advanced breast cancer (1)
- age factors (1)
- aged (1)
- aged 80 and over (1)
- animal models (1)
- anti-hormonal therapy (1)
- anti-tumor effects (1)
- argeted therapy (1)
- ascites (1)
- astrocytic tumor (1)
- astrocytoma (1)
- axillary dissection (1)
- bacteria (1)
- bacterial infection model (1)
- benzoquinone (1)
- bioimpedance analysis (1)
- bioinformatics (1)
- biomarker (1)
- bioreactor culture (1)
- blood lipids; fat loss; running performance (1)
- blood-brain barrier (BBB) model (1)
- bone metastases (1)
- brain metastases (1)
- brain metastasis (1)
- brain-metastasis (1)
- breast cancer imaging (1)
- breast cancer metastases (1)
- breast cancer subtypes (1)
- cachexia (1)
- calprotectin (1)
- cancer cell lines (1)
- cancer cells (1)
- cancer chemotherapy (1)
- cancer dissemination (1)
- cancer microenvironment (1)
- cancer patients (1)
- cancer risk factors (1)
- cancer stem cell immunology (1)
- cancer stem cells (1)
- cancer treatment (1)
- cardiac morbidity (1)
- cardiac mortality (1)
- cell lung cancer (1)
- cervical dysplasia (1)
- chemotherapy (1)
- chronic periodontitis (1)
- claudin 5 (1)
- co-culture (1)
- cohort study (1)
- combinatorial drug predictions (1)
- common variable immunodeficiency (CVID) (1)
- conventional imaging (1)
- cord blood (1)
- cross-sectional imaging (1)
- cytostatic (1)
- cytotoxicity (1)
- delay of therapy (1)
- diseases of the nervous system (1)
- dysplasia (1)
- endocrine therapy (1)
- epidemiology (1)
- evidence‐based medicine (1)
- exercise (1)
- exosomes (1)
- expression pattern (1)
- feasibility (1)
- fecal short-chain fatty acids (1)
- female (1)
- fiber intake (1)
- follow up (1)
- fused deposition modeling (FDM) (1)
- gene expression (1)
- genetic testing (1)
- genital warts (1)
- geographic information science (1)
- glioblastoma (1)
- glioblastoma cell-lines (1)
- glioblastoma multiforme (1)
- glioblastoma stem cell (1)
- glioma (1)
- gliomas (1)
- glucose (1)
- growth (1)
- growth differentiation factor 15 (1)
- guideline adherent treatment (1)
- gynecologic surgical procedures/methods (1)
- health care providers (1)
- health care service research (1)
- histology (1)
- histopathology (1)
- hormona therapy (1)
- hormones (1)
- human genetics (1)
- human induced pluripotent stem cells (hiPSCs)human induced pluripotent stem cells (hiPSCs) (1)
- human papillomavirus (1)
- humanized hemato-lymphoid mice (1)
- hyaluronan-related enzymes (1)
- hypoxia (1)
- immune response (1)
- immunohistochemistry (1)
- immunoresistance (1)
- immunosurveillance (1)
- immunotherapies (1)
- immunotherapy (1)
- implementation (1)
- inborn errors of immunity (IEIs) (1)
- individual mind state (1)
- inflammatory cascades (1)
- insulin (1)
- insulin-like growth factor 1 (IGF1) (1)
- intestinal inflammation (1)
- intestinal permeability (1)
- invasiveness (1)
- ionizing radiation (1)
- ketogenic dients (1)
- ketone bodies (1)
- laparoscopy/methods (1)
- large loop excision of the transformation zone (LLETZ) (1)
- latency (1)
- lifestyle habits (1)
- low carb diet (1)
- low carbohydrate diet (1)
- lung-cancer (1)
- m-Health (1)
- mTOR Inhibitor (1)
- mammography (1)
- matrix metalloproteinase (1)
- medicine (1)
- melanoma (1)
- metabolic profile (1)
- metabolism (1)
- metastasis (1)
- miRNA (1)
- miRNAs (1)
- mice (1)
- microRNA (1)
- microarray (1)
- microbiota (1)
- microglia (1)
- microna profiles (1)
- middle Aged (1)
- modular tumor tissue models (1)
- monocyte (1)
- monocyte subsets (1)
- monocytes (1)
- morphogenesis (1)
- motivational level (1)
- mouse brain (1)
- multiple sclerosis (1)
- multipotent fetal neural stem cells (fNSCs) (1)
- neoadjuvant therapies (1)
- neonatal immunology (1)
- neural stem cell (1)
- neurodegeneration (1)
- neurogenesis (1)
- neuroimmunology (1)
- neuroinflammation (1)
- neurological disorders (1)
- neurovascular unit in vitro (1)
- number of (1)
- p53 (1)
- pathways (1)
- patient safety (1)
- patient serum (1)
- pelvic organ prolapse/surgery (1)
- peripheral blood (1)
- peritoneal metastasis (1)
- pertuzumab (1)
- pilot study (1)
- plaque (1)
- polyvinylidene fluoride (PVDF) (1)
- positive nodal status (1)
- post-neoadjuvant therapies (1)
- postoperative complications/epidemiology (1)
- postpartum (1)
- prediction (1)
- pregnancy gingivitis (1)
- premalignant lesion (1)
- preterm infants (1)
- primary immunodeficiency (1)
- probiotic lozenges (1)
- prognosis (1)
- prognostic marker (1)
- psychological distress (1)
- quality of care (1)
- quality of life (1)
- radiosensibility (1)
- reactive oxygen species (1)
- reconstructive surgical procedures/methods (1)
- regulator (1)
- rehabilitation (1)
- retrospective Studies (1)
- review (1)
- rheumatoid arthritis (1)
- risk (1)
- robotic complications (1)
- robotic hysterectomy (1)
- robotic sacrocolpopexy (1)
- safety (1)
- score (1)
- seahorse (1)
- sentinel (1)
- serum (1)
- signature (1)
- simulation (1)
- skeleton (1)
- staib agar (1)
- staphylocccal infection/epidemiology (1)
- staphylococcal abscess (1)
- stromal hyaluronan (1)
- subgingival (1)
- subventricular zone (1)
- supportive care (1)
- surgical Mesh (1)
- survivors (1)
- symptom burden (1)
- transforming growth factor-beta-1 (1)
- trastuzumab deruxtecan (1)
- tumor associated macrophages (1)
- tumor dormancy (1)
- tumor immune escape (1)
- tumor immunology (1)
- tumor immunosurveillance (1)
- tumor infiltrating lymphocytes (1)
- tumor size (1)
- tumor-associated hyaluronan staining pattern (1)
- tumor-infiltrating lymphocytes (1)
- tumor-propagating cells (1)
- tumors (1)
- tumour immunology (1)
- ultrasound (1)
- unmet needs (1)
- urinary incontinence/surgery (1)
- uterine prolapse/surgery (1)
- vagina/surgery (1)
- vascular permeability (1)
- viral load (1)
- virtual (1)
- virulence (1)
- zonulin (1)
- β-Hydroxybutyrate (1)
Institut
- Frauenklinik und Poliklinik (72) (entfernen)
EU-Projektnummer / Contract (GA) number
- 259867 (1)
Developmentally regulated features of innate immunity are thought to place preterm and term infants at risk of infection and inflammation-related morbidity. Underlying mechanisms are incompletely understood. Differences in monocyte function including toll-like receptor (TLR) expression and signaling have been discussed. Some studies point to generally impaired TLR signaling, others to differences in individual pathways. In the present study, we assessed mRNA and protein expression of pro- and anti-inflammatory cytokines in preterm and term cord blood (CB) monocytes compared with adult controls stimulated ex vivo with Pam3CSK4, zymosan, polyinosinic:polycytidylic acid, lipopolysaccharide, flagellin, and CpG oligonucleotide, which activate the TLR1/2, TLR2/6, TLR3, TLR4, TLR5, and TLR9 pathways, respectively. In parallel, frequencies of monocyte subsets, stimulus-driven TLR expression, and phosphorylation of TLR-associated signaling molecules were analyzed. Independent of stimulus, pro-inflammatory responses of term CB monocytes equaled adult controls. The same held true for preterm CB monocytes—except for lower IL-1β levels. In contrast, CB monocytes released lower amounts of anti-inflammatory IL-10 and IL-1ra, resulting in higher ratios of pro-inflammatory to anti-inflammatory cytokines. Phosphorylation of p65, p38, and ERK1/2 correlated with adult controls. However, stimulated CB samples stood out with higher frequencies of intermediate monocytes (CD14\(^+\)CD16\(^+\)). Both pro-inflammatory net effect and expansion of the intermediate subset were most pronounced upon stimulation with Pam3CSK4 (TLR1/2), zymosan (TR2/6), and lipopolysaccharide (TLR4). Our data demonstrate robust pro-inflammatory and yet attenuated anti-inflammatory responses in preterm and term CB monocytes, along with imbalanced cytokine ratios. Intermediate monocytes, a subset ascribed pro-inflammatory features, might participate in this inflammatory state.
Background: Hyaluronan (HA), a component of the extracellular matrix, is frequently increased under pathological conditions including cancer. Not only stroma cells but also cancer cells themselves synthesize HA, and the interaction of HA with its cognate receptors promotes malignant progression and metastasis. Methods: In the present study, HA deposition in tissue sections was analyzed by hyaluronan-binding protein (HABP) ligand histochemistry in 17 borderline tumors and 102 primary and 20 recurrent ovarian cancer samples. The intensity and, particularly, localization of the HA deposition were recorded: for the localization, the pericellular deposition around the ovarian cancer cells was distinguished from the deposition within the stromal compartment. These histochemical data were correlated with clinical and pathological parameters. Additionally, within a reduced subgroup of ovarian cancer samples (n = 70), the RNA levels of several HA-associated genes were correlated with the HA localization and intensity. Results: Both stroma-localized and pericellular tumor-cell-associated HA deposition were observed. Cancer-cell pericellular HA deposition, irrespective of its staining intensity, was significantly associated with malignancy, and in the primary ovarian cancer cohort, it represents an independent unfavorable prognostic marker for overall survival. Furthermore, a significant association between high CD44, HAS2 and HAS3 mRNA levels and a cancer-cell pericellular HA-deposition pattern was noted. In contrast, stromal hyaluronan deposition had no impact on ovarian cancer prognosis. Conclusions: In conclusion, the site of HA deposition is of prognostic value, but the amount deposited is not. The significant association of only peritumoral cancer-cell HA deposition with high CD44 mRNA expression levels suggests a pivotal role of the CD44–HA signaling axis for malignant progression in ovarian cancer.
A 3D printed model of the female pelvis for practical education of gynecological pelvic examination
(2022)
Background
Pelvic palpation is a core component of every Gynecologic examination. It requires vigorous training, which is difficult due to its intimate nature, leading to a need of simulation. Up until now, there are mainly models available for mere palpation which do not offer adequate visualization of the concerning anatomical structures. In this study we present a 3D printed model of the female pelvis. It can improve both the practical teaching of gynecological pelvic examination for health care professionals and the spatial understanding of the relevant anatomy.
Methods
We developed a virtual, simplified model showing selected parts of the female pelvis. 3D printing was used to create a physical model.
Results
The life-size 3D printed model has the ability of being physically assembled step by step by its users. Consequently, it improves teaching especially when combining it with commercial phantoms, which are built solely for palpation training. This is achieved by correlating haptic and visual sensations with the resulting feedback received.
Conclusion
The presented 3D printed model of the female pelvis can be of aid for visualizing and teaching pelvic anatomy and examination to medical staff. 3D printing provides the possibility of creating, multiplying, adapting and sharing such data worldwide with little investment of resources. Thus, an important contribution to the international medical community can be made for training this challenging examination.
Background
Electrosurgical excisions are common procedures for treating cervical dysplasia and are often seen as minor surgeries. Yet, thorough training of this intervention is required, as there are considerable consequences of inadequate resections, e.g. preterm birth, the risk of recurrence, injuries and many more. Unfortunately, there is a lack of sufficiently validated possibilities of simulating electrosurgeries, which focus on high fidelity and patient safety.
Methods
A novel 3D printed simulator for examination and electrosurgical treatment of dysplastic areas of the cervix was compared with a conventional simulator. Sixty medical students experienced a seminar about cervical dysplasia. Group A underwent the seminar with the conventional and Group B with the novel simulator. After a theoretical introduction, the students were randomly assigned by picking a ticket from a box and went on to perform the hands-on training with their respective simulator. Each student first obtained colposcopic examination training. Then he or she performed five electrosurgical excisions (each). This was assessed with a validated score, to visualize their learning curve. Furthermore, adequate and inadequate resections and contacts between electrosurgical loop and vagina or speculum were counted. Both groups also assessed the seminar and their simulator with 18 questions (Likert-scales, 1–10, 1 = strongly agree / very good, 10 = strongly disagree / very bad). Group B additionally assessed the novel simulator with four questions (similar Likert-scales, 1–10).
Results
Nine of 18 questions showed statistically significant differences favoring Group B (p < 0.05). Group B also achieved more adequate R0-resections and less contacts between electrosurgical loop and vagina or speculum. The learning curves of the performed resections favored the novel simulator of Group B without statistically significant differences. The four questions focusing on certain aspects of the novel simulator indicate high appreciation of the students with a mean score of 1.6 points.
Conclusion
The presented novel simulator shows several advantages compared to the existing model. Thus, novice gynecologists can be supported with a higher quality of simulation to improve their training and thereby patient safety.
Evaluating the value of a 3D printed model for hands-on training of gynecological pelvic examination
(2022)
Background
Simulation in the field of gynecological pelvic examination with educational purposes holds great potential. In the current manuscript we evaluate a 3D printed model of the female pelvis, which improves practical teaching of the gynecological pelvic examination for medical staff.
Methods
We evaluated the benefit of a 3D printed model of the female pelvis (Pelvisio®) as part of a seminar (“skills training”) for teaching gynecological examination to medical students. Each student was randomly assigned to Group A or B by picking a ticket from a box. Group A underwent the skills training without the 3D printed model. Group B experienced the same seminar with integration of the model. Both groups evaluated the seminar by answering five questions on Likert scales (1–10, 1 = “very little” or “very poor”, 10 equals “very much” or “very good”). Additionally, both groups answered three multiple-choice questions concerning pelvic anatomy (Question 6 to 8). Finally, Group B evaluated the 3D printed model with ten questions (Question 9 to 18, Likert scales, 1–10).
Results
Two of five questions concerning the students’ satisfaction with the seminar and their gained knowledge showed statistically significant better ratings in Group B (6.7 vs. 8.2 points and 8.1 vs. 8.9 points (p < 0.001 and p < 0.009). The other three questions showed no statistically significant differences between the traditional teaching setting vs. the 3D printed model (p < 0.411, p < 0.344 and p < 0.215, respectively). The overall mean score of Question 1 to 5 showed 8.4 points for Group B and 7.8 points for Group A (p < 0.001). All three multiple-choice questions, asking about female pelvic anatomy, were answered more often correctly by Group B (p < 0.001, p < 0.008 and p < 0.001, respectively). The mean score from the answers to Questions 9 to 18, only answered by Group B, showed a mean of 8.6 points, indicating, that the students approved of the model.
Conclusion
The presented 3D printed model Pelvisio® improves the education of female pelvic anatomy and examination for medical students. Hence, training this pivotal examination can be supported by a custom designed anatomical model tailored for interactive and explorative learning.
Simple Summary
Anti-hormonal therapie regimes are well established in oncological treatments in breast cancer. In contrast there is limited knowledge of their effects on metastatic brain metastases in advanced breast cancer and their ability to cross the blood brain-barrier. In this review, we point out the usual antihormonal therapy options in the primary disease, but also in metastatic breast cancer. In addition, we explain the epidemiological facts of brain metastases, as well as the basics of the blood-brain barrier and how this is overcome by metastase. Last but not least, we deal with the known anti-hormonal therapy options and present clinical studies on their intracerebral effect, as well as the known basics of their blood-brain barrier penetration. Not all common anti-hormonal therapeutics are able to penetrate the CNS. It is therefore important for the treating oncologists to use substances that have been proven to cross the BBB, despite the limited data available. Aromataseinhibitors, especially letrozole, probably also tamoxifen, everolimus and CDK4/6 inhibitors, especially abemaciclib, appear to act intracerebrally by overcoming the blood-brain barrier. Nevertheless, further data must be obtained in basic research, but also health care research in relation to patients with brain metastases.
Abstract
The molecular receptor status of breast cancer has implications for prognosis and long-term metastasis. Although metastatic luminal B-like, hormone-receptor-positive, HER2−negative, breast cancer causes brain metastases less frequently than other subtypes, though tumor metastases in the brain are increasingly being detected of this patient group. Despite the many years of tried and tested use of a wide variety of anti-hormonal therapeutic agents, there is insufficient data on their intracerebral effectiveness and their ability to cross the blood-brain barrier. In this review, we therefore summarize the current state of knowledge on anti-hormonal therapy and its intracerebral impact and effects on the blood-brain barrier in breast cancer.
MRSA (Methicillin-resistant Staphylococcus aureus) is the second-leading cause of deaths by antibiotic-resistant bacteria globally, with more than 100,000 attributable deaths annually. Despite the high urgency to develop a vaccine to control this pathogen, all clinical trials with pre-clinically effective candidates failed so far. The recent development of “humanized” mice might help to edge the pre-clinical evaluation closer to the clinical situation and thus close this gap. We infected humanized NSG mice (huNSG: (NOD)-scid IL2R\(_γ\)\(^{null}\) mice engrafted with human CD34+ hematopoietic stem cells) locally with S. aureus USA300 LAC* lux into the thigh muscle in order to investigate the human immune response to acute and chronic infection. These mice proved not only to be more susceptible to MRSA infection than wild-type or “murinized” mice, but displayed furthermore inferior survival and signs of systemic infection in an otherwise localized infection model. The rate of humanization correlated directly with the severity of disease and survival of the mice. Human and murine cytokine levels in blood and at the primary site of infection were strongly elevated in huNSG mice compared to all control groups. And importantly, differences in human and murine immune cell lineages surfaced during the infection, with human monocyte and B cell numbers in blood and bone marrow being significantly reduced at the later time point of infection. Murine monocytes in contrast behaved conversely by increasing cell numbers. This study demonstrates significant differences in the in vivo behavior of human and murine cells towards S. aureus infection, which might help to sharpen the translational potential of pre-clinical models for future therapeutic approaches.
Brain metastases are the most severe tumorous spread during breast cancer disease. They are associated with a limited quality of life and a very poor overall survival. A subtype of extracellular vesicles, exosomes, are sequestered by all kinds of cells, including tumor cells, and play a role in cell-cell communication. Exosomes contain, among others, microRNAs (miRs). Exosomes can be taken up by other cells in the body, and their active molecules can affect the cellular process in target cells. Tumor-secreted exosomes can affect the integrity of the blood-brain barrier (BBB) and have an impact on brain metastases forming. Serum samples from healthy donors, breast cancer patients with primary tumors, or with brain, bone, or visceral metastases were used to isolate exosomes and exosomal miRs. Exosomes expressed exosomal markers CD63 and CD9, and their amount did not vary significantly between groups, as shown by Western blot and ELISA. The selected 48 miRs were detected using real-time PCR. Area under the receiver-operating characteristic curve (AUC) was used to evaluate the diagnostic accuracy. We identified two miRs with the potential to serve as prognostic markers for brain metastases. Hsa-miR-576-3p was significantly upregulated, and hsa-miR-130a-3p was significantly downregulated in exosomes from breast cancer patients with cerebral metastases with AUC: 0.705 and 0.699, respectively. Furthermore, correlation of miR levels with tumor markers revealed that hsa-miR-340-5p levels were significantly correlated with the percentage of Ki67-positive tumor cells, while hsa-miR-342-3p levels were inversely correlated with tumor staging. Analysis of the expression levels of miRs in serum exosomes from breast cancer patients has the potential to identify new, non-invasive, blood-borne prognostic molecular markers to predict the potential for brain metastasis in breast cancer. Additional functional analyzes and careful validation of the identified markers are required before their potential future diagnostic use.
Ovarian cancer is the second most common gynecological malignancy in women. More than 70% of the cases are diagnosed at the advanced stage, presenting as primary peritoneal metastasis, which results in a poor 5-year survival rate of around 40%. Mechanisms of peritoneal metastasis, including adhesion, migration, and invasion, are still not completely understood and therapeutic options are extremely limited. Therefore, there is a strong requirement for a 3D model mimicking the in vivo situation. In this study, we describe the establishment of a 3D tissue model of the human peritoneum based on decellularized porcine small intestinal submucosa (SIS) scaffold. The SIS scaffold was populated with human dermal fibroblasts, with LP-9 cells on the apical side representing the peritoneal mesothelium, while HUVEC cells on the basal side of the scaffold served to mimic the endothelial cell layer. Functional analyses of the transepithelial electrical resistance (TEER) and the FITC-dextran assay indicated the high barrier integrity of our model. The histological, immunohistochemical, and ultrastructural analyses showed the main characteristics of the site of adhesion. Initial experiments using the SKOV-3 cell line as representative for ovarian carcinoma demonstrated the usefulness of our models for studying tumor cell adhesion, as well as the effect of tumor cells on endothelial cell-to-cell contacts. Taken together, our data show that the novel peritoneal 3D tissue model is a promising tool for studying the peritoneal dissemination of ovarian cancer.
Parkinson’s disease (PD) is a progressive and debilitating chronic disease that affects more than six million people worldwide, with rising prevalence. The hallmarks of PD are motor deficits, the spreading of pathological α-synuclein clusters in the central nervous system, and neuroinflammatory processes. PD is treated symptomatically, as no causally-acting drug or procedure has been successfully established for clinical use. Various pathways contributing to dopaminergic neuron loss in PD have been investigated and described to interact with the innate and adaptive immune system. We discuss the possible contribution of interconnected pathways related to the immune response, focusing on the pathophysiology and neurodegeneration of PD. In addition, we provide an overview of clinical trials targeting neuroinflammation in PD.